ALC:NYSE
Alcon
74,50 $
0,00%
(0,00) 1D
74,57 $
arrow_upward
+0,09% (+0,070)todayPre-market
Closed: 19 նոյ, 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Mkt. cap
31,33 մլրդ
Avg. vol.
2,43 մլն
Volume
23,21 հզր
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
480,40 մլն
No. of employees
25 հզր
Mkt. cap
31,33 մլրդ
Avg. vol.
2,43 մլն
Volume
23,21 հզր
52-wk high
87,64 $
52-wk low
61,84 $
Beta
0,87
Shares outstanding
480,40 մլն
No. of employees
25 հզր
News stories
From web sources and news partners
TradingView
·
6 ժամ առաջ
Alcon Inc. Stock 12‑Month Price Target Raised to $86.4, Implies 16% Upside
Yahoo Finance
·
15 ժամ առաջ
Why Pershing Square Is Betting Big on Alcon Stock
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon
CEODavid J. Endicott
Employees25 հզր
Founded1945
HeadquartersԺնև, Ժնև, Շվեյցարիա
SectorHealth Care
Industry-
Websitealcon.com